Endocrinology

Trials, guidelines and clinical evidence across Endocrinology.

CGM Time in Range Predicts Microvascular Risk in Type 1 Diabetes

A 5-year real-world study linked worsening CGM time in range with microvascular complications in type 1 diabetes and suggested added prognostic value beyond HbA1c.

By Dr. A. Nikhil Krishnan, MBBS · 2 days ago · 5 min read

Endocrinology·ScienceDaily

Low-Protein Diet May Slow Aging, Review of 350 Studies Finds

A review of more than 350 studies links lower protein intake with slower aging, improved metabolism, and potential…

2 days ago

Endocrinology·Nature

Graves’ disease quality of life varies by treatment in meta-analysis

A meta-analysis of 16 studies found all Graves’ disease treatments improved quality of life, but domain-level gains differed…

2 days ago

Endocrinology·BMJ Open

Semaglutide Real-World Study in Pakistan Shows HbA1c Improvement

A 30-week multicentre study in Pakistan found biosynthetic semaglutide lowered HbA1c in adults with type 2 diabetes in…

3 days ago

Endocrinology·JCI

Early Nutrition Alters Setmelanotide Response in Obese Mice

Mouse data suggest maternal overnutrition can reshape adult response to setmelanotide, with effects tracked across weight loss and…

3 days ago

Endocrinology·Diabetes Care

BMI Normalization Linked to Lower Type 1 Diabetes Progression Risk in Youth

Diabetes Care abstract links BMI normalization with lower progression to type 1 diabetes, with the association strongest in…

3 days ago

Endocrinology·Diabetes Care

Pancreatic Perivascular Adipose Tissue CT Biomarker for Type 2 Diabetes

Diabetes Care examined pancreatic perivascular adipose tissue on CT as a potential imaging biomarker for diagnosing type 2…

3 days ago

Endocrinology·Gut

Obesity Precision Medicine Could Replace One-Size-Fits-All Care

A 2026 review argues that obesity care needs better stratification tools, precision diagnostics, and individualized treatment beyond BMI…

4 days ago

Endocrinology·BMJ Open

Tirzepatide Trial Targets Weight Loss in Type 1 Diabetes With Obesity

BMJ Open protocol for a 32-week trial testing tirzepatide in adults with type 1 diabetes and overweight or…

4 days ago

Endocrinology·BMJ Open

Oral semaglutide carbon footprint lower in MCF than manufacturer LCA

A BMJ Open analysis found oral semaglutide’s carbon footprint was lower with the MCF model than manufacturer LCA,…

4 days ago

Endocrinology

Trials, guidelines and clinical evidence across Endocrinology.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.